Optically Stimulated Luminescence (OSL) materials are advanced technology materials widely used in critical applications from radiation dosimetry, biomedicine, and optical data storage to archaeometry. These materials store energy by trapping charge carriers and convert this energy back into light by optical stimulation. However, there are significant challenges such as control of trap distribution and complete understanding of luminescence mechanisms. This study aims to overcome these challenges by comprehensively investigating the luminescence characteristics of lithium aluminate (LiAlO2) pellet materials produced by the sol-gel method and enabling the development of a new OSL dosimetric material. The crystal structures of the synthesized materials were confirmed by X-Ray Diffraction (XRD) method and their morphologies were investigated by Scanning Electron Microscope (SEM). Detailed discussions on defect concentrations and lattice parameters of LiAlO2 are presented. To obtain promising luminescence signals for passive dosimetry, LiAlO2 were doped with various lanthanides (Ce and Gd) and metals (Cu, Ag, Na, Mg and Ca). Especially, the co-doping of Ag and Na ions provided a significant increase in Thermoluminescence (TL) and OSL signals. The effects of dopant elements on TL and OSL signals were investigated comprehensively, and the OSL components and lifetimes were analyzed in detail. As a result, it was determined that TL traps of the developed LiAlO2:Ag,Na pellets at 100 °C were the main source of OSL signals. The reusable OSL signals and almost linear dose-response ratio up to 2 Gy of this material make it a candidate for radiation dosimetry applications. While the developed LiAlO2:Ag,Na material exhibits promising OSL sensitivity and low fading over 2 weeks, the signal stability is dependent on an initial preheat treatment at 100 °C, which reduces around 80 % of the initial OSL signal associated with shallow traps. This characteristic supports the material’s application in dosimetry but may limit sensitivity in low-dose contexts.
Read full abstract